All for Joomla All for Webmasters
Thursday, 14 December 2017

B Business

Grail wants to develop a test for cancer at the earliest possible stage.

User Rating: 0 / 5

Star InactiveStar InactiveStar InactiveStar InactiveStar Inactive
 

 Illumina, the maker of DNA-sequencing technology, teamed up with a group of Silicon Valley investors to develop a blood test for any kind of cancer at an earlier stage than previously possible.

Using Illumina's technology, a new company called Grail will look for a way to measure circulating nucleic acids — bits of DNA that circulate in the blood outside blood cells. While most of our DNA is inside our cells, scientists use CNAs to test for cancer and other diseases noninvasively. Its ambitious mission: Develop a universal cancer-screening test.

Funding: $100 million from investors, including Arch Venture Partners, Bezos Expeditions, Bill Gates, and Sutter Hill Ventures. Illumina remains majority shareholder.

We are taking on one of the biggest challenges of our lifetime, combining science, technology, and clinical studies to reveal cancer at its beginnings.

‘’To detect cancer early, when it can be cured.‘’

Popular News

Poor 500 Newsletter

Subscribe to get our latest updates and news

Poor 500 @poor500

Tue Apr 17 03:48:55 +0000 2012

Critical medical conditions http://t.co/GKINrNG9
Tue Apr 17 03:47:25 +0000 2012

Critical medical conditions http://t.co/QhVNqG5C via @poor500
Fri Mar 02 08:19:18 +0000 2012

new launch , so soon , get ready for http://t.co/Kvqp1JIl hot version !
Tue Sep 14 02:47:18 +0000 2010

RT @poor500: World Most Cheap Food... - http://tinyurl.com/39ta8ns

We Published Poor 500 to raise awareness and put a spot light on the most suffering people around the world, We don't accept any donations, our main goal is to help the people to live a better live

Email:

Info@poor500.com

Fax:

+01200012324